Results 11 to 20 of about 3,715,352 (131)

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence

Frontiers in Neurology, 2019
Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons, appearance of Lewy bodies and presence of neuroinflammation.
Elisa Storelli, Niccolò Cassina, Emanuela Rasini, Franca Marino, Marco Cosentino   +4 more
doaj   +1 more source

Anticonvulsant Activity of Antiparkinsonism Agents

Experimental Biology and Medicine, 1968
SummaryThe anticonvulsant activity of synthetic antiparkinsonism agents has been studied in mice with experimental seizures and in children with myoclonic spasms refractory to conventional medications. Procyclidine and trihexyphenidyl protected mice from maximal electroshock seizures.
J G, Millichap, G L, Pitchford, M G, Millichap   +2 more
openaire   +2 more sources

Adverse drug reaction to antiparkinson agents in Idiopathic Parkinson Disease: a prospective observational study in a Movement Disorder outpatient clinic

, 2017
Background: Parkinson disease (PD) generally requires therapy for prolonged periods often with multiple drugs; drug-related adverse effects often add to the existing morbidity.
Firoz Thaha, R. Gangadhar, T. Iype, R. Rajan   +3 more
semanticscholar   +1 more source

Evidence-based guidelines for the antipsychotic drugs: Schizophrenia

Psychiatry and Clinical Psychopharmacology, 2021
Antipsychotic medications, as the standard pharmacologic treatment of schizophrenia, are used to decrease symptoms and to increase functioning. The currently available antipsychotics are all significantly efficacious for positive symptoms.
Özcan Uzun
doaj  

Association between Parkinson’s disease and cardiovascular disease mortality: a prospective population-based study from NHANES

Lipids in Health and Disease
Background and aim Conflicting results have been reported on the association between Parkinson's disease (PD) and cardiovascular disease (CVD) mortality in different populations.
Li Ke, Lei Zhao, Wenli Xing, Qiaosheng Tang   +3 more
doaj   +1 more source

Association between hemoglobin glycation index and cognitive function: Evidence in the elderly. [PDF]

PLoS One
Ge L, Guo Y, Xu X, Xu J, Hu M.
europepmc   +1 more source

Pharmacological Interventions for Orthostatic Hypotension: A Systematic Review. [PDF]

Cureus
Verma A, Saraya E, Haque MS, Senaratne M, Khan S, Kasagga A, Malasevskaia IA.   +6 more
europepmc   +1 more source

Long-Term Adherence and Drug Utilisation Patterns Among New Users of Anti-Hyperlipidemic Monotherapy: Development of a Risk Prediction Model. [PDF]

J Eval Clin Pract
Li X, Hak E, Bos JHJ, Schuiling-Veninga CCM, Mubarik S.   +4 more
europepmc   +1 more source

Changes in Gait Speed Vary Widely after the Use of Antiparkinson Medication in Persons with Parkinson's Disease. [PDF]

Mov Disord Clin Pract
Rosenfeldt AB, Lopez-Lennon C, Suttman E, Jansen AE, Zimmerman E, Miller C, Lovati R, Fernandez HH, Imrey PB, Dibble LE, Alberts JL.   +10 more
europepmc   +1 more source

Adamantine Amantadine. [PDF]

J Gen Intern Med
Acosta LMY.
europepmc   +1 more source